Published in Ophthalmology on November 01, 1992
Pterygium excision with conjunctival autografting: an effective and safe technique. Br J Ophthalmol (1993) 2.15
Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol (1998) 1.84
Clinical experiences of infectious scleral ulceration: a complication of pterygium operation. Br J Ophthalmol (1997) 1.68
Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br J Ophthalmol (2006) 1.59
Comparative study of intraoperative mitomycin C and beta irradiation in pterygium surgery. Br J Ophthalmol (2000) 1.56
Who should receive mitomycin-C after pterygium surgery? Ophthalmology (1992) 1.53
Effect of ADCON-L on adjustable strabismus surgery in rabbits. Br J Ophthalmol (2001) 1.46
Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment. Br J Ophthalmol (2000) 1.37
Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium. Br J Ophthalmol (1998) 1.37
Trichostatin a inhibits corneal haze in vitro and in vivo. Invest Ophthalmol Vis Sci (2009) 1.31
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. Graefes Arch Clin Exp Ophthalmol (2005) 1.28
Results of intraoperative mitomycin C application in dacryocystorhinostomy. Br J Ophthalmol (2000) 1.28
Necrotising scleritis after bare sclera excision of pterygium. Br J Ophthalmol (2000) 1.27
Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium. Br J Ophthalmol (2000) 1.23
Comparing techniques for pterygium surgery. Clin Ophthalmol (2009) 1.23
A randomised trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium. Br J Ophthalmol (2004) 1.20
Topical chemotherapy for conjunctival melanoma. Br J Ophthalmol (1993) 1.12
Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. Br J Ophthalmol (1996) 1.12
Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol (1998) 1.11
Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium. Br J Ophthalmol (1995) 1.10
Serious corneoscleral complications after pterygium excision with mitomycin C. Br J Ophthalmol (2002) 1.09
Risk factors for failures of trabeculectomies performed without antimetabolites. Br J Ophthalmol (1999) 1.07
Conjunctivolimbal autograft using a fibrin adhesive in pterygium surgery. Korean J Ophthalmol (2008) 1.03
Photorefractive keratectomy: implications of corneal wound healing. Br J Ophthalmol (1993) 1.00
Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium. Br J Ophthalmol (1995) 0.97
Efficacy of preoperative injection versus intraoperative application of mitomycin in recurrent pterygium surgery. Indian J Ophthalmol (2012) 0.97
Preoperative subconjunctival injection of mitomycin C versus intraoperative topical application as an adjunctive treatment for surgical removal of primary pterygium. Middle East Afr J Ophthalmol (2011) 0.96
Trabeculectomy augmented with mitomycin C application under the scleral flap. Br J Ophthalmol (1998) 0.95
Identification of monoclinic calcium pyrophosphate dihydrate and hydroxyapatite in human sclera using Raman microspectroscopy. Int J Exp Pathol (2009) 0.94
BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo. PLoS One (2013) 0.92
Comparison of limbal-conjunctival autograft and intraoperative 0.02% mitomycin-C for treatment of primary pterygium. Int Ophthalmol (2007) 0.92
Epiphora as a side effect of topical mitomycin C. Br J Ophthalmol (2004) 0.92
Effects of daunorubicin, mitomycin C, azathioprine and cyclosporin A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines. Graefes Arch Clin Exp Ophthalmol (2005) 0.92
An update on the surgical management of pterygium and the role of loteprednol etabonate ointment. Clin Ophthalmol (2014) 0.91
Correction of lower eyelid retraction in thyroid eye disease: a randomised controlled trial of retractor tenotomy with adjuvant antimetabolite versus scleral graft. Br J Ophthalmol (1998) 0.91
Pterygium--an ophthalmic enigma. Br J Ophthalmol (1995) 0.90
Effects of mitomycin C on the expression of proliferating cell nuclear antigen after filtering surgery in rabbits. Graefes Arch Clin Exp Ophthalmol (1997) 0.90
Cyclooxygenase 2 expression in pterygium. Mol Vis (2007) 0.89
Bilateral surgically induced necrotising scleritis with secondary superinfection. Br J Ophthalmol (2005) 0.89
Separate limbal-conjunctival autograft transplantation using the inferior conjunctiva for primary pterygium. Oman J Ophthalmol (2011) 0.88
Superficial keratectomy, PTK, and mitomycin C as a combined treatment option for Salzmann's nodular degeneration: a follow-up of eight eyes. Graefes Arch Clin Exp Ophthalmol (2011) 0.87
Mitomycin C for pterygium: long term evaluation. Br J Ophthalmol (2004) 0.87
Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis. PLoS One (2013) 0.85
Surgical treatment of necrotic scleral calcification using combined conjunctival autografting and an amniotic membrane inlay filling technique. Eye (Lond) (2011) 0.83
The use of mitomycin C with autologous limbal-conjunctival autograft transplantation for management of recurrent pterygium. Clin Ophthalmol (2011) 0.82
Treatment of primary pterygium: Role of limbal stem cells and conjunctival autograft transplantation. Oman J Ophthalmol (2009) 0.81
Mitomycin C and conjunctival autograft for recurrent pterygium. Int Ophthalmol (2007) 0.81
Amniotic membrane transplantation for primary pterygium surgery. J Ophthalmic Vis Res (2008) 0.81
Surgically induced necrotizing scleritis after primary pterygium surgery with conjunctival autograft. Clin Ophthalmol (2011) 0.80
[Operative techniques for surgical treatment of primary and recurrent pterygia]. Ophthalmologe (2010) 0.80
Recurrence rate with use of intraoperative Mitomycin C versus Conjunctival Autograft following pterygium excision. Pak J Med Sci (2015) 0.80
Long term followup of photorefractive keratectomy with adjuvant use of mitomycin C. J Ophthalmol (2014) 0.80
Comparison of efficacy of three surgical methods of conjunctival autograft fixation in the treatment of pterygium. Int Ophthalmol (2014) 0.79
Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up. Strahlenther Onkol (2009) 0.79
Comparison of autologous in situ blood coagulum versus sutures for conjunctival autografting after pterygium excision. Int Ophthalmol (2013) 0.79
Adjustable release of mitomycin C for inhibition of scar tissue formation after filtration surgery. Exp Eye Res (2013) 0.79
Effectiveness of amniotic membrane transplantation combined with mitomycin C in the treatment of pterygium: a meta-analysis. Int J Ophthalmol (2010) 0.79
Topical application of mitomycin C prevents epineural scar formation in rats. Neurosurg Rev (2004) 0.79
Developments and current approaches in the treatment of pterygium. Int Ophthalmol (2016) 0.78
Mitomycin C after pterygium excision. Ophthalmology (1993) 0.78
Repeated bevacizumab injections versus mitomycin C in rotational conjunctival flap for prevention of pterygium recurrence. Indian J Ophthalmol (2014) 0.77
Necrotizing scleritis as a complication of cosmetic eye whitening procedure. J Ophthalmic Inflamm Infect (2013) 0.77
Prospective randomized comparison of mitomycin C application in endoscopic and external dacryocystorhinostomy. Indian J Otolaryngol Head Neck Surg (2011) 0.77
Twelve-Year Outcomes of Pterygium Excision with Conjunctival Autograft versus Intraoperative Mitomycin C in Double-Head Pterygium Surgery. J Ophthalmol (2015) 0.77
Comparison of wide conjunctival flap and conjunctival autografting techniques in pterygium surgery. J Ophthalmol (2013) 0.77
[Pterygium. Etiology, clinical aspects and novel adjuvant therapies]. Ophthalmologe (2010) 0.76
Effect of mitomycin C on the optic nerve in rabbits. Br J Ophthalmol (1997) 0.76
A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery. Korean J Ophthalmol (2015) 0.76
Mitomycin C dissolved in a reversible thermosetting gel: target tissue concentrations in the rabbit eye. Br J Ophthalmol (1997) 0.75
Delayed manifestation of bilateral scleral thinning after I-BRITE(®) procedure and review of literature for cosmetic eye-whitening procedures. Clin Ophthalmol (2015) 0.75
Complications of management in primary acquired melanosis with atypia. Br J Ophthalmol (2007) 0.75
Scleral ulceration after vitreoretinal surgery. Indian J Ophthalmol (2009) 0.75
Nine-Month Follow-up Results of Treatment for Nasolacrimal Duct Obstruction by Probing with Adjunctive Mitomycin C in Adults: A Prospective Randomized Placebo-Controlled Trial. Chonnam Med J (2015) 0.75
Mitomycin-C after pterygium excision. Ophthalmology (1993) 0.75
Pre-operative sub-conjunctival mitomycin C 24 hours before excision of recurrent pterygium. Indian J Ophthalmol (2013) 0.75
Use of an Autologous Lamellar Scleral Graft to Repair a Scleral Melt After Mitomycin Application. Ophthalmol Ther (2014) 0.75
Autologous advanced tenon grafting combined with conjunctival flap in scleromalacia after pterygium excision. J Ophthalmol (2015) 0.75
Autologous cryoprecipitate for attaching conjunctival autografts after pterygium excision. Middle East Afr J Ophthalmol (2013) 0.75
Potential risk of mitomycin C at high concentrations on peripheral nerve structure. Neural Regen Res (2014) 0.75
Pre- and intraoperative mitomycin C for recurrent pterygium associated with symblepharon. Clin Ophthalmol (2013) 0.75
Mitomycin-C after pterygium excision. Ophthalmology (1993) 0.75
Pterygium surgery with mitomycin and tarsorrhaphy. Trans Am Ophthalmol Soc (2005) 0.75
Prophylactic removal and microbiological evaluation of calcified plaques after pterygium surgery. Graefes Arch Clin Exp Ophthalmol (2015) 0.75
Efficacy of postoperative mitomycin-C eye drops on the clinical outcome in endoscopic dacryocystorhinostomy. Graefes Arch Clin Exp Ophthalmol (2015) 0.75
Letter to the Editor: Corneoscleral Melt 50 Years after Excision of Pterygium. Open Ophthalmol J (2017) 0.75
Photodynamic therapy for wound-healing modulation in pterygium surgery. A clinical pilot study. Graefes Arch Clin Exp Ophthalmol (2005) 0.75
New approach for pterygium removal using 20 % ethanol. Int Ophthalmol (2012) 0.75
Pterygium excision with free conjunctival autograft (FCG) versus postoperative strontium 90 (90Sr) beta-irradiation. A prospective study. Int Ophthalmol (1999) 0.75
Scleritis-associated uveitis. Ophthalmology (1997) 7.34
A case-control study of risk factors for postoperative endophthalmitis. Ophthalmology (1991) 4.83
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene (2007) 4.81
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene (2006) 3.09
Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol (1996) 3.04
Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer (2006) 2.76
Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene (2007) 2.68
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Severity of scleritis and episcleritis. Ophthalmology (1994) 2.43
Anterior chamber crystals following hyphema. Arch Ophthalmol (1990) 2.39
Delayed onset keratectasia following laser in situ keratomileusis. J Cataract Refract Surg (1999) 2.38
Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma. Ophthalmology (1999) 2.33
Infectious endophthalmitis. Review of 36 cases. Ophthalmology (1982) 2.26
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer (2012) 2.15
Chemical injuries of the eye. Ophthalmology (1983) 2.10
Cicatricial pemphigoid. Trans Am Ophthalmol Soc (1986) 2.10
Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res (2000) 1.99
Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology (1995) 1.98
The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: a scanning electron microscope study. Invest Ophthalmol (1976) 1.92
Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol (2002) 1.91
Mitomycin eye drops as treatment for pterygium. Ophthalmology (1988) 1.89
Immunomodulatory therapy for chronic tubulointerstitial nephritis-associated uveitis. Am J Ophthalmol (2000) 1.84
The characteristic features of optical coherence tomography in posterior uveitis. Br J Ophthalmol (2007) 1.78
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. Br J Cancer (2009) 1.77
Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. J Clin Psychopharmacol (1994) 1.73
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am J Ophthalmol (1997) 1.71
Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Virchows Arch A Pathol Anat Histol (1982) 1.68
Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea (1991) 1.65
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Br J Cancer (2008) 1.62
Schirmer test after topical anesthesia and the tear meniscus height in normal eyes. Arch Ophthalmol (1979) 1.62
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
Posterior capsule opacification after cataract surgery in patients with uveitis. Ophthalmology (1997) 1.59
Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology (1999) 1.57
An analysis of therapeutic decision for scleritis. Ophthalmology (1993) 1.55
Wegener's granulomatosis: the relationship between ocular and systemic disease. J Rheumatol (2001) 1.55
The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology (1995) 1.54
Ocular features associated with anticardiolipin antibodies: a descriptive study. Am J Ophthalmol (2001) 1.53
Ocular syphilis. Ophthalmology (1990) 1.53
Ocular Whipple's disease: earlier definitive diagnosis. Ophthalmology (2001) 1.50
Ascorbic acid in the treatment of alkali burns of the eye. Ophthalmology (1980) 1.49
Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid. Ophthalmology (1995) 1.48
Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology (1984) 1.46
An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea (1990) 1.46
Corneal laser photocoagulation for treatment of neovascularization. Efficacy of 577 nm yellow dye laser. Ophthalmology (1992) 1.44
Ocular rosacea: patient characteristics and follow-up. Ophthalmology (1997) 1.43
Effect of anterior chamber paracentesis on decreased retinal circulation due to retrobulbar hematoma in dogs. Plast Reconstr Surg (1989) 1.40
Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet (1976) 1.40
Long-term follow-up study of mitomycin eye drops as adjunctive treatment of pterygia and its comparison with conjunctival autograft transplantation. Cornea (1990) 1.40
Molecular basis of disease processes. Hum Pathol (2001) 1.39
Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther (1994) 1.38
Fibronectin in healing rabbit corneal wounds. Lab Invest (1981) 1.37
Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology (1980) 1.35
Comparison of mechanical properties of keratoconus and normal corneas. Exp Eye Res (1982) 1.34
Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology (1999) 1.34
Factors influencing predilection and outcome in bacterial keratitis. Cornea (1989) 1.33
Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol (2001) 1.30
The brown bowel syndrome: a possible smooth muscle mitochondrial myopathy? Histopathology (1979) 1.30
Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology (1997) 1.30
Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. Prostate Cancer Prostatic Dis (2007) 1.29
Intraocular lenses. Experience at the Wilmer Institute. Ophthalmology (1982) 1.28
Bioactivity of peptide analogs of the neutrophil chemoattractant, N-acetyl-proline-glycine-proline. Invest Ophthalmol Vis Sci (1999) 1.28
Differential expression of voltage-activated Na+ currents in two prostatic tumour cell lines: contribution to invasiveness in vitro. FEBS Lett (1995) 1.27
Immunopathology of scleritis. Ophthalmology (1991) 1.27
Gentamicin and renal failure. Lancet (1972) 1.27
Impairment of semantic and figural memory by acute ethanol: age-dependent effects. Alcohol Clin Exp Res (1998) 1.27
Effects of hypotonic saline loading in hydrated dog: evidence for a saline-induced limit on distal tubular sodium transport. J Clin Invest (1967) 1.26
Intermediate uveitis and retinal vasculitis as manifestations of cat scratch disease. Am J Ophthalmol (1996) 1.25
Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management. Cornea (1995) 1.25
Changing patterns in uveitis of childhood. Ophthalmology (1996) 1.24
Squamous cell carcinoma of the conjunctiva. Int Ophthalmol Clin (1997) 1.24
Monoclonal antibodies and human tumor pathology. Hum Pathol (1982) 1.24
Concepts of epigenetics in prostate cancer development. Br J Cancer (2008) 1.24
Miconazole therapy for keratomycosis. Am J Ophthalmol (1981) 1.24
Intraocular pressure changes after alkali burns. Arch Ophthalmol (1974) 1.23
bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol (1996) 1.23
A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis (2005) 1.22
Sarcoidosis and its ocular manifestations. Int Ophthalmol Clin (1996) 1.22
Scleritis associated with systemic vasculitic diseases. Ophthalmology (1995) 1.22
Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology (2001) 1.21
Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. Am J Pathol (1999) 1.20
Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology (1982) 1.19
Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett (1998) 1.18
Basement membrane components in healing rabbit corneal epithelial wounds: immunofluorescence and ultrastructural studies. J Cell Biol (1984) 1.17
Gas-permeable scleral contact lens therapy in ocular surface disease. Am J Ophthalmol (2000) 1.17
Six cases of scleritis associated with systemic infection. Am J Ophthalmol (1992) 1.16
Amniotic membrane surgery. Curr Opin Ophthalmol (2001) 1.15
Topical ascorbate decreases the incidence of corneal ulceration after experimental alkali burns. Invest Ophthalmol Vis Sci (1978) 1.15
Alkali burns of the eye: pathophysiology and treatment. South Med J (1982) 1.15
Collagen crosslinking in keratoconus. Invest Ophthalmol Vis Sci (1978) 1.15
Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol (1999) 1.15
Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology (1995) 1.15
Improved detection of disease progression in ocular cicatricial pemphigoid. Cornea (1992) 1.14
Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology (1994) 1.13
Penetrating keratoplasty for herpes simplex keratitis. Am J Ophthalmol (1981) 1.13
Immunohistopathologic features and therapy of conjunctival lichen planus. Am J Ophthalmol (1993) 1.13
Visual outcome in eight cases of Serratia marcescens keratitis. Am J Ophthalmol (1981) 1.13
Corneal infection in mucosal scarring disorders and Sjögren's syndrome. Am J Ophthalmol (1988) 1.13
Scleral patch graft in the management of necrotizing scleritis. Int Ophthalmol Clin (1999) 1.13